{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:35:10Z","timestamp":1790613310924,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The work was funded by the Max-Planck-Institute of Psychiatry."},{"name":"Max Planck Institute of Psychiatry"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Huntington\u2019s disease (HD) is strongly associated with psychiatric symptoms, yet, associations between huntingtin gene (<jats:italic>HTT<\/jats:italic>) CAG repeat size variations and psychiatric phenotypes outside the HD complex are still under-investigated. In this genetic case-control study we compared the distribution of <jats:italic>HTT<\/jats:italic> CAG repeat sizes in predefined ranges between patients with major depressive disorder (MDD) (<jats:italic>n<\/jats:italic>\u2009=\u20092136) and anxiety disorders (ANX) (<jats:italic>n<\/jats:italic>\u2009=\u2009493), and healthy controls (CON) (<jats:italic>n<\/jats:italic>\u2009=\u20091566). We used regression models to study interactions between the alleles and associations with fine-granular clinical phenotypes and basal ganglia structure. HD mutations in the range of incomplete penetrance (36\u201339 repeats) were not overrepresented in patients. In participants older than 48 years, 13\u201320 repeats on both <jats:italic>HTT<\/jats:italic> alleles were associated with a reduced ANX risk whereas a 13\u201320\u00a0|\u00a021\u201326 combination was associated with an increased ANX risk. Post-hoc analyses confirmed a turning point around 21 repeats and trends in the same direction were detected for MDD. The joint patient\u00a0|\u00a0CON analysis of the full spectrum of allele combinations confirmed interaction effects and age-dependent allele\u00a0|\u00a0risk profiles. A short-by-long interaction effect and an age-dependent negative correlation of the short allele on the nucleus accumbens volume was detected, independently of the diagnostic group. In conclusion, we revealed that <jats:italic>HTT<\/jats:italic> CAG repeat sizes of both alleles in the non-HD range are associated with a risk modulation for common psychiatric disorders as well as basal ganglia structure differences in an age-dependent way, possibly implying that normal variation of the functionally diverse wildtype huntingtin protein may impact brain function.<\/jats:p>","DOI":"10.1038\/s41431-024-01737-1","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T21:42:20Z","timestamp":1732225340000},"page":"624-632","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Huntingtin CAG repeat size variations below the Huntington\u2019s disease threshold: associations with depression, anxiety and basal ganglia structure"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0820-8036","authenticated-orcid":false,"given":"Magdalena","family":"Vater","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2079-5555","authenticated-orcid":false,"given":"Nicolas","family":"Rost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrud","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Tontsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Erhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Lucae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Br\u00fcckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2805-4652","authenticated-orcid":false,"given":"Thomas","family":"Klopstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8523-3628","authenticated-orcid":false,"given":"Philipp G.","family":"S\u00e4mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7088-6618","authenticated-orcid":false,"given":"Elisabeth B.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"1737_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Prim. 2015;1:15005.","journal-title":"Nat Rev Dis Prim"},{"key":"1737_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/0092-8674(87)90029-8","volume":"50","author":"TC Gilliam","year":"1987","unstructured":"Gilliam TC, Tanzi RE, Haines JL, Bonner TI, Faryniarz AG, Hobbs WJ, et al. Localization of the Huntington\u2019s disease gene to a small segment of chromosome 4 flanked by D4S10 and the telomere. Cell. 1987;50:565\u201371.","journal-title":"Cell"},{"key":"1737_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella JF, Wexler NS, Michael Conneally P, Naylor SL, Anderson MA, Tanzi RE, et al. A polymorphic DNA marker genetically linked to Huntington\u2019s disease. Nature. 1983;306:234\u20138.","journal-title":"Nature"},{"key":"1737_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. Lancet. 2007;369:218\u201328.","journal-title":"Lancet"},{"key":"1737_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.31887\/DCNS.2007.9.2\/arosenblatt","volume":"9","author":"A Rosenblatt","year":"2007","unstructured":"Rosenblatt A. Neuropsychiatry of Huntington\u2019s disease. Dialogues Clin Neurosci. 2007;9:191\u20137.","journal-title":"Dialogues Clin Neurosci"},{"key":"1737_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1176\/appi.neuropsych.11030057","volume":"24","author":"JC Thompson","year":"2012","unstructured":"Thompson JC, Harris J, Sollom AC, Stopford CL, Howard E, Snowden JS, et al. Longitudinal evaluation of neuropsychiatric symptoms in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci. 2012;24:53\u201360.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1737_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/jnp.2007.19.4.441","volume":"19","author":"E van Duijn","year":"2007","unstructured":"van Duijn E, Kingma EM, van der Mast RC. Psychopathology in verified Huntington\u2019s disease gene carriers. J Neuropsychiatry Clin Neurosci. 2007;19:441\u20138.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1737_CR8","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1136\/jnnp-2013-307343","volume":"85","author":"E van Duijn","year":"2014","unstructured":"van Duijn E, Craufurd D, Hubers AAM, Giltay EJ, Bonelli R, Rickards H, et al. Neuropsychiatric symptoms in a European Huntington\u2019s disease cohort (REGISTRY). J Neurol, Neurosurg Psychiatry. 2014;85:1411\u20138.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"1737_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra0905980","volume":"363","author":"TA Manolio","year":"2010","unstructured":"Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166\u201376.","journal-title":"N Engl J Med"},{"key":"1737_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neuron.2010.10.003","volume":"68","author":"PF Sullivan","year":"2010","unstructured":"Sullivan PF. The psychiatric GWAS consortium: big science comes to psychiatry. Neuron. 2010;68:182\u20136.","journal-title":"Neuron"},{"key":"1737_CR11","doi-asserted-by":"publisher","unstructured":"Gardiner SL, van Belzen MJ, Boogaard MW, van Roon-Mom WMC, Rozing MP, van Hemert AM et al. Huntingtin gene repeat size variations affect risk of lifetime depression. Transl Psychiatry. 2017;7. https:\/\/doi.org\/10.1038\/s41398-017-0042-1.","DOI":"10.1038\/s41398-017-0042-1"},{"key":"1737_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1212\/WNL.0000000000002858","volume":"87","author":"C Kay","year":"2016","unstructured":"Kay C, Collins JA, Miedzybrodzka Z, Madore SJ, Gordon ES, Gerry N, et al. Huntington disease reduced penetrance alleles occur at high frequency in the general population. Neurology. 2016;87:282\u20138.","journal-title":"Neurology"},{"key":"1737_CR13","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1038\/gim.2014.146","volume":"16","author":"L Bean","year":"2014","unstructured":"Bean L, Bayrak-Toydemir P. American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease. Genet Med. 2014;16:e2.","journal-title":"Genet Med"},{"key":"1737_CR14","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/mds.26001","volume":"29","author":"JF Gusella","year":"2014","unstructured":"Gusella JF, MacDonald ME, Lee J-M. Genetic modifiers of Huntington\u2019s disease. Mov Disord. 2014;29:1359\u201365.","journal-title":"Mov Disord"},{"key":"1737_CR15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","volume":"11","author":"SJ Tabrizi","year":"2012","unstructured":"Tabrizi SJ, Reilmann R, Roos RAC, Durr A, Leavitt B, Owen G, et al. Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol. 2012;11:42\u201353.","journal-title":"Lancet Neurol"},{"key":"1737_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s00415-010-5768-0","volume":"258","author":"SJA Bogaard","year":"2011","unstructured":"Bogaard SJA, TRACK-HD Investigator Group, Dumas EM, Acharya TP, Johnson H, Langbehn DR, et al. Early atrophy of pallidum and accumbens nucleus in Huntington\u2019s disease. J Neurol. 2011;258:412\u201320.","journal-title":"J Neurol"},{"key":"1737_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3233\/JHD-130076","volume":"2","author":"EH Aylward","year":"2013","unstructured":"Aylward EH, Harrington DL, Mills JA, Nopoulos PC, Ross CA, Long JD, et al. Regional atrophy associated with cognitive and motor function in prodromal Huntington disease. J Huntingt Dis. 2013;2:477\u201389.","journal-title":"J Huntingt Dis"},{"key":"1737_CR18","doi-asserted-by":"publisher","unstructured":"Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SMD, Hyare H et al. Clinical impairment in premanifest and early Huntington\u2019s disease is associated with regionally specific atrophy. Human Brain Mapp. 2011. https:\/\/doi.org\/10.1002\/hbm.21449.","DOI":"10.1002\/hbm.21449"},{"key":"1737_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1017\/S1355617716001132","volume":"23","author":"MB Misiura","year":"2017","unstructured":"Misiura MB, Lourens S, Calhoun VD, Long J, Bockholt J, Johnson H, et al. Cognitive control, learning, and clinical motor ratings are most highly associated with basal ganglia brain volumes in the premanifest Huntington\u2019s Disease Phenotype. J Int Neuropsychol Soc. 2017;23:159\u201370.","journal-title":"J Int Neuropsychol Soc"},{"key":"1737_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.parkreldis.2017.11.001","volume":"46","author":"EM Coppen","year":"2018","unstructured":"Coppen EM, Jacobs M, van den Berg-Huysmans AA, van der Grond J, Roos RAC. Grey matter volume loss is associated with specific clinical motor signs in Huntington\u2019s disease. Parkinsonism Relat Disord. 2018;46:56\u201361.","journal-title":"Parkinsonism Relat Disord"},{"key":"1737_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.nicl.2016.02.014","volume":"11","author":"AV Faria","year":"2016","unstructured":"Faria AV, Ratnanather JT, Tward DJ, Lee DS, van den Noort F, Wu D, et al. Linking white matter and deep gray matter alterations in premanifest Huntington disease. Neuroimage Clin. 2016;11:450\u201360.","journal-title":"Neuroimage Clin"},{"key":"1737_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/neup.12578","volume":"39","author":"M Hirano","year":"2019","unstructured":"Hirano M, Iritani S, Fujishiro H, Torii Y, Habuchi C, Sekiguchi H, et al. Clinicopathological differences between the motor onset and psychiatric onset of Huntington\u2019s disease, focusing on the nucleus accumbens. Neuropathology. 2019;39:331\u201341.","journal-title":"Neuropathology"},{"key":"1737_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/mds.25717","volume":"29","author":"ER Fisher","year":"2014","unstructured":"Fisher ER, Hayden MR. Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk. Mov Disord. 2014;29:105\u201314.","journal-title":"Mov Disord"},{"key":"1737_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1399-0004.2010.01538.x","volume":"80","author":"PJ Morrison","year":"2011","unstructured":"Morrison PJ, Harding-Lester S, Bradley A. Uptake of Huntington disease predictive testing in a complete population. Clin Genet. 2011;80:281\u20136.","journal-title":"Clin Genet"},{"key":"1737_CR25","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","volume":"84","author":"SJW Evans","year":"2013","unstructured":"Evans SJW, Douglas I, Rawlins MD, Wexler NS, Tabrizi SJ, Smeeth L. Prevalence of adult Huntington\u2019s disease in the UK based on diagnoses recorded in general practice records. J Neurol Neurosurg Psychiatry. 2013;84:1156\u201360.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1737_CR26","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1176\/appi.ajp.2009.09070973","volume":"167","author":"RH Perlis","year":"2010","unstructured":"Perlis RH, Smoller JW, Mysore J, Sun M, Gillis T, Purcell S, et al. Prevalence of incompletely penetrant Huntington\u2019s disease alleles among individuals with major depressive disorder. Am J Psychiatry. 2010;167:574\u20139.","journal-title":"Am J Psychiatry"},{"key":"1737_CR27","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1212\/WNL.0b013e318294b304","volume":"80","author":"A Killoran","year":"2013","unstructured":"Killoran A, Biglan KM, Jankovic J, Eberly S, Kayson E, Oakes D, et al. Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROS. Neurology. 2013;80:2022\u20137.","journal-title":"Neurology"},{"key":"1737_CR28","doi-asserted-by":"publisher","unstructured":"Ha AD, Beck CA, Jankovic J. Intermediate CAG Repeats in Huntington\u2019s Disease: Analysis of COHORT. Tremor Other Hyperkinet Mov 2012;2. https:\/\/doi.org\/10.7916\/D8FF3R2P.","DOI":"10.7916\/D8FF3R2P"},{"key":"1737_CR29","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuron.2011.04.005","volume":"70","author":"MA Kohli","year":"2011","unstructured":"Kohli MA, Lucae S, Saemann PG, Schmidt MV, Demirkan A, Hek K, et al. The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron. 2011;70:252\u201365.","journal-title":"Neuron"},{"key":"1737_CR30","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jpsychires.2008.05.002","volume":"43","author":"JM Hennings","year":"2009","unstructured":"Hennings JM, Owashi T, Binder EB, Horstmann S, Menke A, Kloiber S, et al. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients \u2013 Findings from the Munich Antidepressant Response Signature (MARS) project. J Psychiatr Res. 2009;43:215\u201329.","journal-title":"J Psychiatr Res"},{"key":"1737_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2012.85","volume":"2","author":"A Erhardt","year":"2012","unstructured":"Erhardt A, Akula N, Schumacher J, Czamara D, Karbalai N, M\u00fcller-Myhsok B, et al. Replication and meta-analysis of TMEM132D gene variants in panic disorder. Transl Psychiatry. 2012;2:e156.","journal-title":"Transl Psychiatry"},{"key":"1737_CR32","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/ng1479","volume":"36","author":"EB Binder","year":"2004","unstructured":"Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, P\u00fctz B, et al. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet. 2004;36:1319\u201325.","journal-title":"Nat Genet"},{"key":"1737_CR33","doi-asserted-by":"publisher","unstructured":"Bastepe M, Xin W. Huntington Disease: Molecular Diagnostics Approach. Current Protocols in Human Genetics. 2015;87. https:\/\/doi.org\/10.1002\/0471142905.hg0926s87.","DOI":"10.1002\/0471142905.hg0926s87"},{"key":"1737_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289\u2013300.","journal-title":"J R Stat Soc"},{"key":"1737_CR35","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/archpsyc.1984.01790230022003","volume":"41","author":"MM Weissman","year":"1984","unstructured":"Weissman MM, Wickramaratne P, Merikangas KR, Leckman JF, Prusoff BA, Caruso KA, et al. Onset of major depression in early adulthood. Increased familial loading and specificity. Arch Gen Psychiatry. 1984;41:1136\u201343.","journal-title":"Arch Gen Psychiatry"},{"key":"1737_CR36","unstructured":"Piscopo K, Lipari RN, Cooney J, Glasheen C. Suicidal thoughts and behavior among adults: Results from the 2015 National Survey on Drug Use and Health. NSDUH Data Review; Department of Health & Human Services. 2016."},{"key":"1737_CR37","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s10038-005-0343-8","volume":"51","author":"MdoC Costa","year":"2006","unstructured":"Costa MdoC, Magalh\u00e3es P, Guimar\u00e3es L, Maciel P, Sequeiros J, Sousa A. The CAG repeat at the Huntington disease gene in the Portuguese population: insights into its dynamics and to the origin of the mutation. J Hum Genet. 2006;51:189\u201395.","journal-title":"J Hum Genet"},{"key":"1737_CR38","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jmg.38.4.e12","volume":"38","author":"A Maat-Kievit","year":"2001","unstructured":"Maat-Kievit A. New problems in testing for Huntington\u2019s disease: the issue of intermediate and reduced penetrance alleles. J Med Genet. 2001;38:12e.12.","journal-title":"J Med Genet"},{"key":"1737_CR39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1399-0004.2010.01388.x","volume":"78","author":"J Sequeiros","year":"2010","unstructured":"Sequeiros J, Ramos EM, Cerqueira J, Costa MC, Sousa A, Pinto-Basto J, et al. Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population. Clin Genet. 2010;78:381\u20137.","journal-title":"Clin Genet"},{"key":"1737_CR40","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","volume":"78","author":"J-M Lee","year":"2012","unstructured":"Lee J-M, Ramos EM, Lee J-H, Gillis T, Mysore JS, Hayden MR, et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012;78:690\u20135.","journal-title":"Neurology"},{"key":"1737_CR41","doi-asserted-by":"publisher","unstructured":"Schmaal L, Veltman DJ, van Erp TG, S\u00e4mann PG, Frodl T, Jahanshad N et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry 2016;21. https:\/\/doi.org\/10.1038\/mp.2015.69.","DOI":"10.1038\/mp.2015.69"},{"key":"1737_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/bs.irn.2018.09.006","volume":"142","author":"H Wilson","year":"2018","unstructured":"Wilson H, Dervenoulas G, Politis M. Structural magnetic resonance imaging in huntington\u2019s disease. Int Rev Neurobiol. 2018;142:335\u201380.","journal-title":"Int Rev Neurobiol"},{"key":"1737_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00415-009-0052-x","volume":"256","author":"SMD Henley","year":"2009","unstructured":"Henley SMD, Wild EJ, Hobbs NZ, Scahill RI, Ridgway GR, Macmanus DG, et al. Relationship between CAG repeat length and brain volume in premanifest and early Huntington\u2019s disease. J Neurol. 2009;256:203\u201312.","journal-title":"J Neurol"},{"key":"1737_CR44","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/mds.21620","volume":"22","author":"R Jech","year":"2007","unstructured":"Jech R, Klemp\u00edr J, Vymazal J, Zidovsk\u00e1 J, Klemp\u00edrov\u00e1 O, R\u016fzicka E, et al. Variation of selective gray and white matter atrophy in Huntington\u2019s disease. Mov Disord. 2007;22:1783\u20139.","journal-title":"Mov Disord"},{"key":"1737_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fneur.2016.00147","volume":"7","author":"JA Ciarochi","year":"2016","unstructured":"Ciarochi JA, Calhoun VD, Lourens S, Long JD, Johnson HJ, Bockholt HJ, et al. Patterns of co-occurring gray matter concentration loss across the huntington disease prodrome. Front Neurol. 2016;7:147.","journal-title":"Front Neurol"},{"key":"1737_CR46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/jnnp.2007.116244","volume":"79","author":"HH Ruocco","year":"2008","unstructured":"Ruocco HH, Bonilha L, Li LM, Lopes-Cendes I, Cendes F. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat. J Neurol Neurosurg Psychiatry. 2008;79:130\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1737_CR47","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/jnr.23980","volume":"95","author":"JK Lee","year":"2017","unstructured":"Lee JK, Ding Y, Conrad AL, Cattaneo E, Epping E, Mathews K, et al. Sex-specific effects of the huntington gene on normal neurodevelopment. J Neurosci Res. 2017;95:398.","journal-title":"J Neurosci Res"},{"key":"1737_CR48","doi-asserted-by":"publisher","first-page":"424.e1","DOI":"10.1016\/j.neurobiolaging.2010.09.027","volume":"33","author":"LW de Jong","year":"2012","unstructured":"de Jong LW, Wang Y, White LR, Yu B, van Buchem MA, Launer LJ. Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study. Neurobiol Aging. 2012;33:424.e1\u201310.","journal-title":"Neurobiol Aging"},{"key":"1737_CR49","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S. The biology of huntingtin. Neuron. 2016;89:910\u201326.","journal-title":"Neuron"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01737-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:17:40Z","timestamp":1746191860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-024-01737-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1737"],"URL":"https:\/\/doi.org\/10.1038\/s41431-024-01737-1","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"1 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The RUD and the MARS project were approved by the respective responsible Ethics Committee of the Bayerische Landes\u00e4rztekammer and the Ludwig Maximilian University of Munich, Germany. Written informed consent was obtained from all participants after the respective study protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}